Lilly Looks to Align U.S. Drug Prices with Other Nations Under Trump’s MFN Plan, Cites 340B ‘Abuse’ as Factor in Higher Costs 

Eli Lilly recently announced it’s working on certain pharmaceutical pricing changes to comply with President Donald Trump’s "most-favored nation" executive order.
An Indiana-based pharmaceutical giant recently announced that it’s working to align its U.S. drug prices with those paid by other [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two Drugmakers Sue Maine Over 340B Contract Pharmacy Law; Key Lawmaker Condemns Move

Drugmakers AbbVie and Novartis recently challenged Maine's 340B contract pharmacy access law in federal court.
Two major drugmakers recently filed lawsuits challenging Maine’s new 340B contract pharmacy access law, drawing sharp criticism from an influential [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Novartis Exempts South Dakota, Colorado from 340B Contract Pharmacy Restrictions

Novartis recently exempted North Dakota and Colorado from its 340B contract pharmacy restrictions.
A Swiss pharmaceutical giant this week announced new 340B contract pharmacy restriction exemptions for two states that recently enacted contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Analysis: PhRMA Member Restrictions on Health Centers Have More Than Doubled Since NACHC-PhRMA Alliance Formed

A 340B Report analysis finds that a significant number of PhRMA members placed 340B contract pharmacy restrictions on health centers after the NACHC-PhRMA alliance formed in March 2023.
The number of drugmakers that have placed 340B contract pharmacy restrictions on health centers has more than doubled since the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two Drugmakers Sue Rhode Island Over 340B Contract Pharmacy Access Law

Drugmakers AbbVie and Novartis recently filed federal lawsuits challenging Rhode Island's new 340B contract pharmacy access law.
Two large pharmaceutical companies this week filed the first federal lawsuits challenging Rhode Island’s recently enacted 340B contract pharmacy access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: Briefs in Colorado, Tennessee, Utah and Hawaii

Key briefs were filed this week in state 340B contract pharmacy litigation in Colorado, Tennessee, Utah and Hawaii.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sobi, J&J Exempt New States from 340B Contract Pharmacy Restrictions

Drugmakers Sobi and Johnson & Johnson recently announced additional 340B contract pharmacy restriction exemptions for states that have enacted new contract pharmacy access laws.
Two major drugmakers recently announced additional 340B contract pharmacy restriction exemptions for states that have enacted new contract pharmacy access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

In Unanimous Decision, Fed Appeals Court Reverses Lower Court Ruling and Allows 340B Antitrust Lawsuit Against Insulin Drugmakers to Advance

The U.S. 2nd Circuit Court of Appeals' 3-0 decision reversed a lower court’s 2024 ruling that had denied health centers' antitrust claims against four drug manufacturers that have placed contract pharmacy restrictions.
A federal appeals court ruled unanimously Wednesday that an antitrust class action lawsuit, in which two health clinics alleged four [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HHS Touts 340B Rebate Pilot Proposal to Appeals Court, Hospitals File Amicus Brief Urging Court to Reject Rebates

HHS highlighted its proposed 340B rebate pilot in an Aug. 1 brief filed with the U.S. Court of Appeals for the District of Columbia Circuit.
The U.S. Department of Health and Human Services (HHS) touted the agency’s recently announced plan to pilot a 340B rebate [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Trump Calls on Drugmakers to Implement ‘Most Favored Nation’ Pricing, Resurrects Idea to Extend MFN to all Medicaid Patients

President Donald Trump sent a July 31 letter to 17 major drugmakers to begin implementing his proposed “most-favored nation” model for prescription drugs.
President Donald Trump is urging more than a dozen leading pharmaceutical manufacturers to begin implementing his proposed “most-favored nation” (MFN) [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live